.

Deeper Knowledge, Faster

  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Chinese Patent Office
Federal Trade Commission
Dow
Deloitte
Julphar
Chubb
Accenture
QuintilesIMS
Moodys
Fish and Richardson

Generated: June 27, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017284

« Back to Dashboard
NDA 017284 describes XENON XE 133, which is a drug marketed by Mallinkrodt Nuclear, Gen Electric, Ge Healthcare, and Lantheus Medcl, and is included in six NDAs. It is available from two suppliers. Additional details are available on the XENON XE 133 profile page.

The generic ingredient in XENON XE 133 is xenon xe-133. There are eleven drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the xenon xe-133 profile page.

Summary for NDA: 017284

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Formulation / Manufacturing:see details

Pharmacology for NDA: 017284

Mechanism of ActionRadiopharmaceutical Activity

Suppliers and Packaging for NDA: 017284

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
XENON XE 133
xenon xe-133
GAS;INHALATION 017284 NDA Lantheus Medical Imaging, Inc. 11994-127 11994-127-11 1 VIAL in 1 CAN (11994-127-11) > 1 GAS in 1 VIAL
XENON XE 133
xenon xe-133
GAS;INHALATION 017284 NDA Lantheus Medical Imaging, Inc. 11994-127 11994-127-15 5 VIAL in 1 CAN (11994-127-15) > 1 GAS in 1 VIAL

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:GAS;INHALATIONStrength10mCi/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Summary for product number 002

Active Rx/OTC/Discontinued:RXDosage:GAS;INHALATIONStrength20mCi/VIAL
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Cantor Fitzgerald
Baxter
Merck
Queensland Health
Argus Health
Healthtrust
US Department of Justice
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot